SCHEMBL6890929

SCHEMBL6890929

COc1cc2c3c(c4c(c2cc1N1CCOCC1)C=CC(c1ccccc1)(c1ccc(N2CCOCC2)cc1)O4)Cc1ccccc1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK10 O94804 1/20 0.35
SLK Q9H2G2 1/20 0.35
CHEK1 O14757 1/20 0.34
PIK3CA P42336 1/20 0.34
LMNA P02545 4/20 0.34
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6888729 0.92 BCHE (0.32) LMNAKDM4EMAPTMEN1KMT2A
SCHEMBL6888923 0.90 STK10 (0.33) STK10SLKCHEK1PIK3CALMNA
SCHEMBL6889466 0.85 LPAR5 (0.30)
SCHEMBL5101461 0.84 MEN1 (0.33) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL6888011 0.84 STK10 (0.34) STK10SLKPIK3CALMNAALDH1A1
SCHEMBL13880288 0.83 STK10 (0.36) STK10SLKCHEK1PIK3CALMNA
SCHEMBL25838234 0.82 CHEK1 (0.34) STK10SLKCHEK1PIK3CALMNA
SCHEMBL11995963 0.81 PIK3CA (0.35) STK10SLKPIK3CALMNAALDH1A1
SCHEMBL25605060 0.81 PIK3CA (0.35) STK10SLKPIK3CALMNAALDH1A1
SCHEMBL25716431 0.79 PIK3CA (0.34) STK10SLKPIK3CALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686468-B2 FOR USE IN SYNTHETIC RESINS TO OBTAIN VIOLET TO BLUE TINTS; USED IN PHOTOTROPIC GLASSES OPTISCHE WERKE G. RODENSTOCK (DE) 2004-02-03 US claimed
EP-1235823-B1 H-ANNELLATED BENZO [F]CHROMENES RODENSTOCK OPTIK G (DE) 2003-07-16 EP claimed
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses RODENSTOCK GMBH (DE) 2003-02-27 US claimed
US-6686468-B2 FOR USE IN SYNTHETIC RESINS TO OBTAIN VIOLET TO BLUE TINTS; USED IN PHOTOTROPIC GLASSES OPTISCHE WERKE G. RODENSTOCK (DE) 2004-02-03 US disclosed
EP-1235823-B1 H-ANNELLATED BENZO [F]CHROMENES RODENSTOCK OPTIK G (DE) 2003-07-16 EP disclosed
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses RODENSTOCK GMBH (DE) 2003-02-27 US disclosed
EP-1235823-A1 H-ANNELLATED BENZO F]CHROMENES Optische Werke G. Rodenstock (DE) 2002-09-04 EP disclosed
WO-2002022594-A1 H-ANNELLATED BENZO[F]CHROMENES OPTISCHE WERKE G. RODENSTOCK (DE) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040623-A1 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses NR2E3, RB1, BRD7 STK10 2370/4885SLK 3046/4885CHEK1 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.